Company Filing History:
Years Active: 1987-1988
Title: Neil E. Willmer: Innovator in Antibiotic Compounds
Introduction
Neil E. Willmer is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of antimicrobial compounds, holding a total of 2 patents. His work focuses on the development of antibiotic compounds that exhibit both antimicrobial and antitumor properties.
Latest Patents
Willmer's latest patents include the CL-1957E antibiotic compound and its production. This patent describes a purified isolate of an actinomycete identified as ATCC 39366, which is capable of producing the antimicrobial compound CL-1957E. The compound is produced by cultivating isolate ATCC 39366 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen. The process continues until a substantial quantity of the CL-1957E compound is produced, followed by its isolation. The patent also discloses pharmaceutical compositions comprising CL-1957E, along with methods for treating microbial infections and tumors in mammals.
Another significant patent is for the CL-1957D antibiotic compound and its production. Similar to the previous patent, this invention involves the cultivation of the same actinomycete isolate under aerobic conditions to produce the antimicrobial compound CL-1957D. The patent outlines the methods for isolating the CL-1957D compound and describes pharmaceutical compositions that include this substance, aimed at treating microbial infections in mammals.
Career Highlights
Neil E. Willmer is associated with Warner-Lambert Company, where he has contributed to the advancement of antibiotic research. His innovative work has positioned him as a key figure in the development of new antimicrobial therapies.
Collaborations
Willmer has collaborated with notable coworkers, including Richard H. Bunge and James C. French. Their combined efforts have furthered research in the field of antibiotic compounds.
Conclusion
Neil E. Willmer's contributions to antibiotic research through his patents on CL-1957E and CL-1957D highlight his role as an innovator in the field. His work continues to impact the development of new treatments for microbial infections and tumors.